Levomethadon G.L. Pharma (Levomethadone Hydrochloride)

Levomethadone acts as a full agonist at mu‑opioid receptors in the central nervous system. By activating these receptors, it blocks pain signals and produces analgesia, while also mimicking the effects of other opioids to lessen cravings and withdrawal in dependent patients.

The appropriate dose of Levomethadon G.L. Pharma is determined by the prescribing clinician based on the patient’s condition, severity of pain or dependence, and individual response. Dosage adjustments are made according to clinical judgment and patient monitoring.

Safety data for levomethadone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and decisions should be made in consultation with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levomethadone is the levo‑enantiomer of methadone, offering similar analgesic potency with a potentially more favorable side‑effect profile. Compared with morphine or oxycodone, it has a longer half‑life, which can reduce dosing frequency but requires careful monitoring for accumulation and cardiac effects.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture, heat and direct sunlight to maintain stability and potency.

Levomethadon G.L. Pharma is administered orally, typically as a tablet or capsule taken with water. The exact route and timing are directed by the prescribing clinician, who may advise taking it with or without food based on individual tolerance.

The most serious risks include respiratory depression, which can be life‑threatening, especially when combined with other depressants, and cardiac arrhythmias such as QT prolongation. Patients should be monitored closely for signs of severe sedation, breathing difficulties or abnormal heart rhythms.

Levomethadon is contraindicated in patients with known hypersensitivity to levomethadone or other opioids, those with severe respiratory insufficiency, uncontrolled asthma, or significant CNS depression. It should also be avoided in individuals taking MAO inhibitors within the past 14 days.